NOVEL TUBULIN INHIBITORS AND METHODS OF USING THE SAME
申请人:Chen Meng-Hsin
公开号:US20120172374A1
公开(公告)日:2012-07-05
Compounds represented by the formula (I) or pharmaceutically acceptable salts thereof:
R
2
—Y—Z-Q-A-R
1
Formula (I)
wherein R
1
, R
2
, Y, Z, Q, and A are as defined. These compounds are inhibitors of tubulin polymerization by binding at colchicines binding site and are useful in the treatment of tumors or mitotic diseases such as cancers, gout, and other conditions associated with abnormal cell proliferation.
[EN] NOVEL TUBULIN INHIBITORS AND METHODS OF USING THE SAME<br/>[FR] NOUVEAUX INHIBITEURS DE TUBULINE ET PROCÉDÉS POUR LES UTILISER
申请人:DEV CENTER BIOTECHNOLOGY
公开号:WO2012092471A2
公开(公告)日:2012-07-05
Compounds represented by the formula (I) or pharmaceutically acceptable salts thereof: R2-Y-Z-Q-A-R1 Formula (I) wherein R1, R2, Y, Z, Q, and A are as defined. These compounds are inhibitors of tubulin polymerization by binding at colchicines binding site and are useful in the treatment of tumors or mitotic diseases such as cancers, gout, and other conditions associated with abnormal cell proliferation.
Tubulin inhibitors and methods of using the same
申请人:Chen Meng-Hsin
公开号:US08883793B2
公开(公告)日:2014-11-11
Compounds represented by the formula (I) or pharmaceutically acceptable salts thereof:
R2—Y—Z-Q-A-R1 Formula (I)
wherein R1, R2, Y, Z, Q, and A are as defined. These compounds are inhibitors of tubulin polymerization by binding at colchicines binding site and are useful in the treatment of tumors or mitotic diseases such as cancers, gout, and other conditions associated with abnormal cell proliferation.